Related Experiment Video
Updated: May 22, 2025
11:32
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
6.7K
OTUB1 promotes glioma progression by stabilizing TRAF4
Hongjun Liu1, Shasha Tan1, Zhou Li2
1Department of Neurosurgery, The Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Cellular Signalling
|March 16, 2025
Summary
OTUB1 overexpression promotes glioma growth by stabilizing TRAF4. Inhibiting OTUB1 significantly reduced tumor progression and may offer a new therapeutic strategy for glioma patients.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Glioma is a heterogeneous brain tumor with a poor prognosis.
- Identifying novel therapeutic targets is crucial for improving glioma patient outcomes.
Purpose of the Study:
- To investigate the functional role of OTUB1 in glioma.
- To determine OTUB1's impact on TRAF4 stability and its implications for glioma progression.
Main Methods:
- Analysis of single-cell sequencing data from 12 glioma patients.
- Western blot, qPCR, immunoprecipitation, and ubiquitination assays to assess OTUB1 and TRAF4.
- In vitro and in vivo experiments to evaluate the effect of OTUB1 on glioma cell behavior and tumor growth.
Main Results:
- OTUB1 is significantly overexpressed in glioma tissues and correlates with poor patient outcomes.
- OTUB1 knockdown inhibits glioma cell proliferation, migration, and invasion while increasing apoptosis.
- OTUB1 stabilizes TRAF4 by inhibiting its ubiquitination, promoting tumor growth.
Conclusions:
- OTUB1 plays a critical role in glioma progression.
- OTUB1 represents a potential novel therapeutic target for glioma treatment.
- Targeting OTUB1 with inhibitors may improve outcomes for glioma patients.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
01:16TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
02:17Microtubule Instability
4.9K
Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
4.9K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K